Asgard Therapeutics AB
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Asgard Therapeutics AB - overview
Established
2018
Location
Lund, -, Sweden
Primary Industry
Biotechnology
About
Founded in 2018 and based in Lund, Sweden, Asgard Therapeutics, a spin-off from Lund University, is a biotechnology company that develops cancer immunotherapies based on cell fate reprogramming. In March 2024, Asgard Therapeutics AB raised EUR 30 million in series A funding co-led by investors RV Invest GmbH and Johnson & Johnson Innovation, with participation from other investors Novo Holdings, Boehringer Ingelheim Venture, and Industrifonden. The firm as of July 2024, is led by its co-founders, Cristiana Pires (CEO), Fábio Rosa (Head of Research), and Filipe Pereira (Head of Innovation). Asgard Therapeutics' lead program, AT-108, leverages its TrojanDC concept to create off-the-shelf gene therapies that convert cancer cells into antigen-presenting cells, thus facilitating immune responses against tumors.
The company's approach addresses common challenges in traditional cell-based therapies, such as logistics and manufacturing. Additionally, its platform enhances scalability and efficiency in immunotherapy. The company plans to utilize the March 2024 funding to support the development of its technology and for team expansion.
Current Investors
Novo Holdings, Industrifonden, Boehringer Ingelheim Venture
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Oncology/Cancer Treatment
Website
www.asgardthx.com
Verticals
HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
Asgard Therapeutics AB - timeline of key events
Asgard Therapeutics AB - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.